Search - tctmd.com

Displaying 321 - 335 of 335

Sort: Relevancy | Date

News Daily News

Meta-analysis Gives Edge to PFO Closure for Stroke Protection

July 17, 2012

News Daily News

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Caitlin E. Cox

July 16, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

Yael L. Maxwell

June 27, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Cerebrovascular Event Risk Highest in First 24 Hours After TAVR

March 06, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Industry News

On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence Toward Maintaining Patients With Less Warfarin

April 05, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Kim Dalton

September 03, 2009

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Advertisement

Meta-analysis Gives Edge to PFO Closure for Stroke Protection

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Cerebrovascular Event Risk Highest in First 24 Hours After TAVR

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

On-X Heart Valve PROACT Trial Preliminary Report Provides Evidence Toward Maintaining Patients With Less Warfarin

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content